Učitavanje...
Feasibility study of FDG PET as an indicator of early response to aromatase inhibitors and trastuzumab in a heterogeneous group of breast cancer patients
BACKGROUND: In breast cancer endocrine therapy, post-therapy Ki-67 assay of biopsy material predicts recurrence-free survival but is invasive and prone to sampling error. [(18)F]Fluorodeoxyglucose (FDG) positron emission tomography (PET) has shown an early agonist or ‘flare’ response to tamoxifen an...
Spremljeno u:
Glavni autori: | , , , , , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Springer
2012
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3444390/ https://ncbi.nlm.nih.gov/pubmed/22731662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-219X-2-34 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|